US 8378071
Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis
granted A61KA61K38/00A61P
Quick answer
US patent 8378071 (Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61P, A61P19/10, A61P29/00